SCHEMBL7585771

SCHEMBL7585771

COc1cc2nc(N)nc(-c3ccccc3O)c2cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.57
DHFR P00374 2/20 0.49
KMT2A Q03164 4/20 0.48
KDM4E B2RXH2 1/20 0.48
TP53 P04637 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MEN1 O00255 2/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
HCRTR1 O43613 1/20 0.47
GAA P10253 1/20 0.47
HTT P42858 1/20 0.47
WHR1 P49842 1/20 0.47
XBP1 P17861 1/20 0.45
EGFR P00533 1/20 0.44
CHEK1 O14757 1/20 0.44
CHEK2 O96017 1/20 0.44
LRRK2 Q5S007 1/20 0.44
HSP90AA1 P07900 2/20 0.44
HSP90AB1 P08238 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7790975 0.90 ADORA2A (0.51) ADORA2ADHFRKMT2AKDM4ETP53
SCHEMBL7799233 0.85 ADORA2A (0.62) ADORA2ADHFRKMT2AMEN1MAPT
SCHEMBL7790971 0.84 ADORA2A (0.57) ADORA2ADHFRKMT2AMEN1WHR1
SCHEMBL7791023 0.84 ADORA2A (0.57) ADORA2ADHFRKMT2AMEN1WHR1
SCHEMBL7791033 0.84 ADORA2A (0.61) ADORA2ADHFRKMT2ATP53MEN1
SCHEMBL7800422 0.84 ADORA2A (0.57) ADORA2ADHFRKMT2ATP53MEN1
SCHEMBL7800398 0.82 ADORA2A (0.55) ADORA2ADHFRKMT2AKDM4ETP53
SCHEMBL7799250 0.81 ADORA2A (0.53) ADORA2ADHFRWHR1EGFRHSP90AA1
SCHEMBL1257435 0.80 WHR1 (0.71) ADORA2ADHFRKDM4ENPSR1WHR1
SCHEMBL30759714 0.80 WHR1 (0.71) ADORA2ADHFRKDM4ENPSR1WHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109336828-B Quinazoline derivative and preparation method and application thereof 雅安职业技术学院 2022-04-26 CN disclosed
CN-105924433-B Substituted aminopyrimidine compounds and use method and application thereof 广东东阳光药业有限公司 2020-12-22 CN disclosed
CN-104603147-A Hexadepsipeptide analogues as anticancer compounds PIRAMAL ENTPR LTD 2015-05-06 CN disclosed
CN-103830662-A Application of traditional Chinese medicine composition in preparation of drug for inhibiting rheumatoid arthritis angiogenesis SHIJIAZHUANG YILING PHARMACEUTICAL CO LTD 2014-06-04 CN disclosed
CN-103417907-A Application of traditional Chinese medicine composition in preparation of medicine for inhibiting angiogenesis SHIJIAZHUANG YILING PHARMACEUTICAL CO LTD 2013-12-04 CN disclosed
CN-101578279-B Amide substituted indazoles as poly (ADP ribose) polymerase (PARP) inhibitors ANGELETTI P IST RICHERCHE BIO 2013-07-17 CN disclosed
CN-101068811-A Inhibitors of AKT activity MERCK & CO INC (US) 2007-11-07 CN disclosed
EP-1232146-A1 4-(4'-HYDROXYPHENYL)AMINO-6,7-DIMETHOXYQUINAZOLINE TO PREVENT DEVELOPMENT OF COLORECTAL CANCER Parker Hughes Institute (US) 2002-08-21 EP disclosed
WO-2001036394-A1 4-(4'-HYDROXYPHENYL)AMINO-6,7-DIMETHOXYQUINAZOLINE TO PREVENT DEVELOPMENT OF COLORECTAL CANCER PARKER HUGHES INSTITUTE (US) 2001-05-25 WO disclosed
WO-2001035952-A2 RADIOSENSITIZATION OF HUMAN GLIOBLASTOMA CELLS BY QUINAZOLINE COMPOUNDS PARKER HUGUES INSTITUTE (US) 2001-05-25 WO disclosed